Aecom vs ResMed Inc. — how do they compare? Aecom trades at $67.03 (market cap $8.62B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 3.8× Aecom's market cap, and Aecom pays the higher dividend (1.77%). Which is the better fit depends on your goals.
| ACM | RMD | |
|---|---|---|
Market Cap | $8.62B | $32.61B |
Sector | Industrials | Health |
52-Week High | $134.35 | $293.73 |
52-Week Low | $66.86 | $182.82 |
Enterprise Value | $10.81B | $31.97B |
Dividend Yield | 1.77% | 1.17% |
Trailing returns across standard periods
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →